ClinicalTrialsFinder

Genetic Diseases, Inborn Clinical Trials in Nashville, Tennessee

1 recruitingNashville, Tennessee

Showing 1–1 of 1 trials

Recruiting
Phase 3

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Beta-ThalassemiaSickle Cell DiseaseHematologic Diseases+4 more
Vertex Pharmaceuticals Incorporated26 enrolled6 locationsNCT05477563